---
schema_version: "secwatch.filing_event.v1"
accession: "0000947871-23-000994"
form_type: "8-K"
ticker: "CVS"
cik: "0000064803"
company_name: "CVS HEALTH Corp"
filed_at: "2023-10-16T23:59:59+00:00"
generated_at: "2026-06-09T23:40:47.059424+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# CVS CFO Shawn Guertin takes leave; Tom Cowhey named interim CFO; Mike Pykosz interim Health Svcs Pres

## Summary
- Guertin's leave effective immediately for unforeseen family medical reasons; Cowhey (SVP Corporate Finance) appointed interim CFO.
- Mike Pykosz, CEO of Oak Street Health, named interim President of Health Services, assuming Guertin's dual role.
- FY2023 GAAP EPS guidance reaffirmed at $6.53-$6.75; Adjusted EPS reaffirmed at $8.50-$8.70.
- Q3 earnings call remains Nov 1, 2023; Investor Day remains Dec 5, 2023, as previously scheduled.

## SEC filing metadata
- accession: 0000947871-23-000994
- form_type: 8-K
- ticker: CVS
- cik: 0000064803
- company_name: CVS HEALTH Corp
- filed_at: 2023-10-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/64803/000094787123000994/0000947871-23-000994-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/64803/000094787123000994/ss2584510_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000947871-23-000994
- JSON: https://secwatch.observer/filing/0000947871-23-000994.json
- Plain text: https://secwatch.observer/filing/0000947871-23-000994.txt

## Key facts
- Executive change
  Shawn M. Guertin departed as Executive Vice President and Chief Financial Officer at CVS HEALTH Corp.
  - Action: began a personal leave of absence
  - Role: Executive Vice President and Chief Financial Officer
  source text: Effective October 13, 2023, Shawn M. Guertin, the Executive Vice President and Chief Financial Officer of CVS Health Corporation (“CVS Health,” the “Company,” “we” or “our”), has begun a personal leave of absence for unforeseen family medical reasons.
  evidence_url: https://www.sec.gov/Archives/edgar/data/64803/000094787123000994/0000947871-23-000994-index.htm
- Executive change
  Thomas F. Cowhey was appointed as Interim Chief Financial Officer at CVS HEALTH Corp.
  - Action: appointed
  - Role: Interim Chief Financial Officer
  source text: Appointment of Interim Chief Financial Officer In connection with Mr. Guertin’s leave, the Company’s Board of Directors appointed Thomas F. Cowhey, Senior Vice President, Corporate Finance, to serve as the Company’s Interim Chief Financial Officer, effective October 13, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/64803/000094787123000994/0000947871-23-000994-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.